Cameron Groome
Chief Executive Officer at MICROBIX BIOSYSTEMS INC.
Net worth: 743 576 $ as of 2024-03-30
Profile
Cameron L.
Groome is currently the President, Chief Executive Officer & Director at Microbix Biosystems, Inc. since 2017.
He is also an Independent Director at iFabric Corp.
since 2020.
Previously, he served as the President, Chief Executive Officer & Director at Avivagen, Inc. from 2014 to 2017.
He was also a Director at ScarX Therapeutics, Inc. Additionally, he held the position of Executive VP-Corporate & Strategic Development at Telesta Therapeutics, Inc. from 2011 to 2012.
Earlier in his career, he worked as an Analyst at National Bank Financial, Inc. Mr. Groome completed his undergraduate degree at Concordia University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MICROBIX BIOSYSTEMS INC.
1.94% | 2024-02-22 | 2,645,500 ( 1.94% ) | 719 576 $ | 2024-03-30 |
IFABRIC CORP.
0.08% | 2024-02-04 | 25,000 ( 0.08% ) | 24 000 $ | 2024-03-30 |
Cameron Groome active positions
| Companies | Position | Start |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Chief Executive Officer | 2017-07-23 |
| IFABRIC CORP. | Director/Board Member | 2020-03-29 |
Former positions of Cameron Groome
| Companies | Position | End |
|---|---|---|
ScarX Therapeutics, Inc.
 ScarX Therapeutics, Inc. BiotechnologyHealth Technology ScarX Therapeutics, Inc. engages in the provision of biotechnology services. It discovers and develops innovative treatments for dermal scarring. The company was founded by Benjamin Alman in 2012 and is headquartered in Ontario, Canada. | Director/Board Member | 2018-02-28 |
| AVIVAGEN INC. | Chief Executive Officer | 2017-02-08 |
| TELESTA THERAPEUTICS INC | Corporate Officer/Principal | 2012-07-29 |
National Bank Financial, Inc. (Broker)
 National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Analyst-Equity | 2002-05-13 |
Training of Cameron Groome
| Concordia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| AVIVAGEN INC. | Health Technology |
| Private companies | 4 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
National Bank Financial, Inc. (Broker)
National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance National Bank Financial, Inc. (Broker) (NBF-Broker) is the broker/dealer division of National Bank Financial, Inc., a Canadian mutual fund manager headquartered in Montréal, Quebec. The firm was founded in 1902 and is a direct subsidiary of National Bank Acquisition Holding, Inc., ultimately owned by National Bank of Canada (TSX: NA). NBF-Broker provides retail advisory and brokerage services with institutional brokerage, investment banking, corporate finance and securities clearing services for third parties. The firm has a substantial presence in all regions of Canada, as well as operations in the US and Europe. | Finance |
| iFabric Corp. | |
ScarX Therapeutics, Inc.
ScarX Therapeutics, Inc. BiotechnologyHealth Technology ScarX Therapeutics, Inc. engages in the provision of biotechnology services. It discovers and develops innovative treatments for dermal scarring. The company was founded by Benjamin Alman in 2012 and is headquartered in Ontario, Canada. | Health Technology |
- Stock Market
- Insiders
- Cameron Groome
